21370433

Source:http://linkedlifedata.com/resource/pubmed/id/21370433

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0206624, umls-concept:C0220901, umls-concept:C0373538, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2709058, umls-concept:C2911692
pubmed:issue	4
pubmed:dateCreated	2011-8-9
pubmed:abstractText	We evaluated the outcomes and prognostic factors, especially serum levels of alpha-fetoprotein (AFP) and their changes during the treatment of hepatoblastoma (HB).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101186624
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/AFP protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1545-5017
pubmed:author	pubmed-author:BaeKeun WookKW, pubmed-author:ImHo JoonHJ, pubmed-author:KimBo EunBE, pubmed-author:KimKyung MoKM, pubmed-author:KohKyung NamKN, pubmed-author:ParkMeerimM, pubmed-author:SeoJong JinJJ
pubmed:copyrightInfo	Copyright © 2011 Wiley-Liss, Inc.
pubmed:issnType	Electronic
pubmed:volume	57
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	554-60
pubmed:meshHeading	pubmed-meshheading:21370433-Adolescent, pubmed-meshheading:21370433-Age Factors, pubmed-meshheading:21370433-Antineoplastic Agents, pubmed-meshheading:21370433-Area Under Curve, pubmed-meshheading:21370433-Chemotherapy, Adjuvant, pubmed-meshheading:21370433-Child, pubmed-meshheading:21370433-Child, Preschool, pubmed-meshheading:21370433-Combined Modality Therapy, pubmed-meshheading:21370433-Disease-Free Survival, pubmed-meshheading:21370433-Female, pubmed-meshheading:21370433-Hepatectomy, pubmed-meshheading:21370433-Hepatoblastoma, pubmed-meshheading:21370433-Humans, pubmed-meshheading:21370433-Infant, pubmed-meshheading:21370433-Kaplan-Meier Estimate, pubmed-meshheading:21370433-Liver Neoplasms, pubmed-meshheading:21370433-Male, pubmed-meshheading:21370433-Neoadjuvant Therapy, pubmed-meshheading:21370433-Prognosis, pubmed-meshheading:21370433-ROC Curve, pubmed-meshheading:21370433-Retrospective Studies, pubmed-meshheading:21370433-Sensitivity and Specificity, pubmed-meshheading:21370433-Treatment Outcome, pubmed-meshheading:21370433-Tumor Markers, Biological, pubmed-meshheading:21370433-Young Adult, pubmed-meshheading:21370433-alpha-Fetoproteins
pubmed:year	2011
pubmed:articleTitle	Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
pubmed:affiliation	Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
pubmed:publicationType	Journal Article